Madrid

• A Phase 1 Study of TAS0612 in Patients with Locally Advanced or Metastatic Solid Tumors Ended
  2024-515175-35-00 1 2021-02-10 Locally Advanced or Metastatic Solid Tumors
• A Phase 1 Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations Ended
  2024-516369-36-00 3 2021-02-09 - Acute myeloid leukemia - Myelodysplastic syndrome/ Myeloproliferativ
• A Phase 1 Study of HMPL-306 in Locally Advanced Solid Tumors with IDH mutations Ended
  2024-516370-30-00 3 2021-02-09 - Locally advanced or metastatic solid tumors - Cholangiocarcinoma - S
• Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure Ended
  2023-504165-23-00 5 2021-02-08 Acute decompensated heart failure
• A Phase 3, Open-label, Single Arm, Multicenter Study of Ravulizumab in Addition to Best Supportive Care in Pediatric Participants (from 1 mo … Ended
  2023-507850-33-00 5 2021-02-05 Hematopoietic stem cell transplant-associated thrombotic microangiopat
• A Clinical Trial to Test the Safety, Effect, and Activity of Rilzabrutinib (PRN1008) in Adult and Adolescent Patients with Persistent or Chr … Ended
  2023-509401-71-00 5 2021-02-05 Immune Thrombocytopenia (ITP)
• An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outc … Ended
  2024-510663-34-00 4 2021-01-29 Influenza, Human
• This is a randomized, double-blinded, Placebo controlled trial that will evaluate the potential of tildacerfont to reduce glucocorticoid use … Ended
  2023-503771-13-00 4 2021-01-28 Classic Congenital Adrenal Hyperplasia
• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer (CERPASS) Ended
  2024-512652-38-00 4 2021-01-25 Cutaneous Squamous Cell Carcinoma
• Study to Investigate the Efficacy and Safety of CS1003 in Combination with Lenvatinib Compared to Placebo in Combination with Lenvatinib in … Ended
  2024-517331-48-00 5 2021-01-18 Unresectable advanced hepatocellular carcinoma
• A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Anti-TNF Experien … Ended
  2023-507415-35-00 5 2021-01-15 Psoriatic Arthritis
• Mogamulizumab Every 4 Week dosing in Participants with R/R CTCL Ended
  2024-515921-27-00 4 2021-01-13 Mycosis fungoides/Sezary syndrome recurrent
• This is a randomized, double-blinded, Placebo controlled trial with a 3-part treatment period that will evaluate the efficacy and safety of … Ended
  2023-503770-21-00 4 2021-01-05 Classic Congenital Adrenal Hyperplasia
• A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inop … Ended
  2024-512331-72-00 5 2020-12-22 Squamous Carcinoma of the Anal Canal
• Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants wit … Ended
  2023-508443-40-00 5 2020-12-18 Lung Cancer, Non-Small Cell
• A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small C … Ended
  2024-516598-60-00 5 2020-12-18 Advanced Non-Squamous Non-Small Cell Lung Cancer
• A Study of Tiragolumab in Combination with Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin versus Pembrolizumab Plus Pemetrexed and C … Ended
  2022-502031-20-00 10 2020-12-17 Non-squamous non-small cell lung cancer (NSCLC)
• A Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Liver Cancer who have never been been Treated with Immuno- … Ended
  2023-503519-13-00 4 2020-12-14 Advanced Hepatocellular Carcinoma
• Study of Orally Administered CA-4948(IRAK4i) as a Monotherapy in patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome Ended
  2024-513313-13-00 9 2020-12-09 Acute Myelogenous Leukemia (AML) or higher-risk Myelodysplastic Syndro
• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2) Ended
  2023-506724-85-00 5 2020-11-19 Migraine
• A Phase 1b/2 Study of Abemaciclib Plus Chemotherapy and/or Chemoimmunotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory … Ended
  2023-506778-11-00 9 2020-11-11 Relapsed/Refractory Solid Tumors
• A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid Ended
  2024-510745-34-00 10 2020-11-11 Bullous Pemphigoid
• A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1) Ended
  2023-506253-38-00 5 2020-11-09 Migraine
• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor tolebrutinib (SAR442168) (PERSEUS) Ended
  2024-514495-41-00 5 2020-11-04 Primary Progressive Multiple Sclerosis

Showing 3,313–3,336 of 3,550 trials